Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Primary Care · Hypercatabolic Hypoproteinemia

Your Care Team and First Visit

At a Glance

Evaluation of hypercatabolic hypoproteinemia is often coordinated by primary care and may involve kidney, digestive, immune, metabolic-genetics, and nutrition specialists. Bring dated albumin, total protein, and IgG trends, prior urine and stool tests, imaging, and a timeline of major illnesses.

Managing hypercatabolic hypoproteinemia often requires a “diagnostic home” and coordination across specialists. Because this condition sits at the intersection of many different body systems, you will likely need a team of specialists who can look past the symptoms to find the metabolic cause [1][2]. A primary care clinician often coordinates the initial evaluation, and referrals are made when findings remain unexplained.

Building Your Specialist Team

While a primary care doctor or internal medicine specialist often coordinates your care, you may need to see several sub-specialists to rule out common “look-alikes” before a hypercatabolic diagnosis can be considered:

  • Nephrologist: To rule out protein leaking through the kidneys (Nephrotic Syndrome) [3].
  • Gastroenterologist: To rule out protein leaking through the gut (Protein-Losing Enteropathy) using stool tests or endoscopies [4][5].
  • Immunologist: To manage low IgG levels, review infection history, and help decide if you need antibody replacement therapy (IVIG) [6][7].
  • Metabolic Specialist / Biochemical Geneticist: This is a key specialist for rare disorders like suspected FIHH. They focus on rare diseases and can provide genetic counseling and broader testing [1][8]. (Note that there may be no validated routine FcRn-function clinical assay, and a negative genetic test does not always exclude the condition.)
  • Registered Dietitian: To create a “nutrition prescription” that safely matches your body’s specialized needs [2][9].

Preventing the “Repeat Workup”

Because this diagnosis is rare, new specialists may be tempted to repeat the same basic tests you have already had. To move the process forward, you should bring a “Diagnostic Passport” to your first appointment [10][3].

Essential Records to Bring:

  1. The Lab Trend Report: Don’t just bring your latest labs. Bring a folder (or a simple spreadsheet) that shows your Albumin, Total Protein, and IgG levels over the last several months or years. This helps specialists see if the problem is a sudden “spike” (suggesting a temporary illness) or a long-term “baseline” (suggesting a genetic form) [10].
  2. The “Rule-Out” Results: Bring the actual reports for your 24-hour urine protein and fecal alpha-1-antitrypsin clearance, not just the summaries. These are the “keys” that unlock the next level of testing [4][3].
  3. Specialized Imaging: If you have had an “albumin scan” (scintigraphy) or any lymphatic imaging (which are not routine, but sometimes ordered to evaluate specific suspected protein-loss or lymphatic problems), bring the raw images on a CD or digital portal, not just the written report [11].
  4. The Trigger Timeline: Write down a timeline of any “stress events”—surgeries, major burns, severe infections (like sepsis), or hospital stays. This helps the team determine if your condition is acquired (caused by stress) or idiopathic (occurring on its own) [12][10].

Choosing the Right Center

If you suspect you have the rare genetic form (FIHH), a referral to an academic medical center with a dedicated “Rare and Undiagnosed Disease” program or a strong department of “Biochemical Genetics” can be very helpful [1]. These centers are more likely to have the advanced tools and multidisciplinary teams needed [13].

Note on Clinical Trials: Because these conditions are rare, standard treatments are often limited. Ask your team if there are any active clinical trials or research registries (that you can verify through recognized registry websites) for patients with unexplained hypercatabolism or FcRn pathway disorders [14].

Common questions in this guide

Which specialists may be involved in evaluating hypercatabolic hypoproteinemia?
A primary care clinician or internist often coordinates the evaluation. A nephrologist, gastroenterologist, immunologist, metabolic specialist or biochemical geneticist, and registered dietitian may help assess kidney or gut protein loss, low IgG, rare genetic causes, and nutrition needs.
What should I bring to my first appointment for unexplained low protein levels?
Bring dated trends for albumin, total protein, and IgG rather than only your latest results. Also bring reports from 24-hour urine protein and stool alpha-1-antitrypsin testing, any relevant imaging or images, and a timeline of surgeries, burns, severe infections, or hospital stays.
How do doctors check whether protein is being lost through the kidneys or gut?
A 24-hour urine protein test can help assess protein loss through the kidneys, while stool alpha-1-antitrypsin clearance can help assess protein loss through the intestine. In selected cases, clinicians may consider albumin scintigraphy or lymphatic imaging to investigate where protein is going.
When might I need a biochemical geneticist for FIHH?
A biochemical geneticist or metabolic specialist may be helpful when kidney and intestinal protein loss have not explained the low protein levels and a rare genetic or protein-recycling disorder is suspected. They can discuss genetic counseling and broader testing, but a negative genetic test does not always rule out the condition.
Could low IgG lead to treatment with IVIG?
An immunologist reviews your IgG level, infection history, and overall clinical picture before deciding whether antibody replacement with IVIG is appropriate. Low IgG alone does not automatically mean IVIG is needed, so the decision should be individualized.
Can a nitrogen balance study show how quickly my body is breaking down protein?
A nitrogen balance study or urinary total nitrogen measurement may help quantify protein breakdown, but your care team will decide whether it is useful and how to interpret it. These tests are part of a broader evaluation and do not by themselves identify the cause of low albumin or IgG.

Get notified when new evidence is published on hypoproteinemia, hypercatabolic.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Common metabolic disorder (inborn errors of metabolism) concerns in primary care practice.

    Agana M, Frueh J, Kamboj M, et al.

    Annals of translational medicine 2018; (6(24)):469 doi:10.21037/atm.2018.12.34.

    PMID: 30740400
  2. 2

    Protein-losing enteropathy as a result of colon polyposis and colon cancer: a multidisciplinary approach to diagnosis and treatment.

    Kuipers H, van Westreenen HL, Moll FCP, de Vos Tot Nederveen Cappel WH

    BMJ case reports 2024; (17(8)) doi:10.1136/bcr-2024-261081.

    PMID: 39159982
  3. 3

    Nephrotic Syndrome Without Nephrotic Range Proteinuria.

    Sheikh JA, Syed U, Osama SM

    Cureus 2024; (16(7)):e64342 doi:10.7759/cureus.64342.

    PMID: 39131015
  4. 4

    [Protein-losing enteropathy].

    Parfenov AI, Krums LM

    Terapevticheskii arkhiv 2017; (89(2)):4-9 doi:10.17116/terarkh20178924-9.

    PMID: 28281508
  5. 5

    A case of protein-losing enteropathy caused by sclerosing mesenteritis diagnosed with capsule endoscopy and double-balloon endoscopy.

    Saito Y, Hiramatsu K, Nosaka T, et al.

    Clinical journal of gastroenterology 2017; (10(4)):351-356 doi:10.1007/s12328-017-0755-y.

    PMID: 28664384
  6. 6

    Risk factors for cytomegalovirus reactivation during the treatment of ANCA-associated vasculitis: A retrospective cohort study of the J-CANVAS study.

    Kawamori K, Oguro N, Shimizu K, et al.

    Modern rheumatology 2025; (35(4)):691-696 doi:10.1093/mr/roaf008.

    PMID: 39887020
  7. 7

    A Systematic Review and Meta-regression Analysis on the Impact of Increasing IgG Trough Level on Infection Rates in Primary Immunodeficiency Patients on Intravenous IgG Therapy.

    Lee JL, Mohamed Shah N, Makmor-Bakry M, et al.

    Journal of clinical immunology 2020; (40(5)):682-698 doi:10.1007/s10875-020-00788-5.

    PMID: 32417999
  8. 8

    Whole exome sequencing identifies three novel variants and establishes the molecular diagnosis of ATP6V0A4-related distal renal tubular acidosis in a lebanese infant.

    Hachem T, Abou Jaoude P, Salem N, Chebly A

    Molecular biology reports 2026; (53(1)).

    PMID: 42593562
  9. 9

    Estimating Catabolism: A Possible Tool for Nutritional Monitoring of Patients With Acute Kidney Injury.

    Bufarah MN, de Góes CR, Cassani de Oliveira M, et al.

    Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2017; (27(1)):1-7 doi:10.1053/j.jrn.2016.09.002.

    PMID: 27810170
  10. 10

    Empiric anti-Giardia therapy in non-diarrheal protein-losing enteropathy: A focus on children with monogenic humoral immunodeficiency.

    Farsi TA, Ahmed K, Sukaiti NA

    Qatar medical journal 2023; (2023(2)):24 doi:10.5339/qmj.2023.sqac.24.

    PMID: 38025329
  11. 11

    Egested Feces Revealed Massive Protein Loss in 99mTc-HSA-D Scintigraphy.

    Matsusaka Y, Nakahara T, Iwabuchi Y, et al.

    Clinical nuclear medicine 2020; (45(7)):e329-e330 doi:10.1097/RLU.0000000000003080.

    PMID: 32433159
  12. 12

    Albumin Supplementation Preserves Systemic Antioxidant Defenses in Critically Ill, Septic Patients: A Prospective Comparative Study.

    Domokos K, Szirmay B, Farkas N, et al.

    Biomedicines 2026; (14(10)) doi:10.3390/biomedicines14102156.

    PMID: 42939963
  13. 13

    Quantification of Neonatal Fc Receptor and Beta-2 Microglobulin in Human Liver Tissues by Ultraperformance Liquid Chromatography-Multiple Reaction Monitoring-based Targeted Quantitative Proteomics for Applications in Biotherapeutic Physiologically-based Pharmacokinetic Models.

    Qiu X, Wang MZ

    Drug metabolism and disposition: the biological fate of chemicals 2020; (48(10)):925-933 doi:10.1124/dmd.120.000075.

    PMID: 32723849
  14. 14

    Diagnosis of inborn errors of metabolism through massive DNA sequencing: benefits and limitations.

    Ordoñez-Labastida V, Zenteno JC

    Gaceta medica de Mexico 2025; (161(1)):28-32 doi:10.24875/GMM.24000361.

    PMID: 40532251

This page describes how a care team may evaluate hypercatabolic hypoproteinemia and how to prepare for a first visit. It is for informational purposes only and does not constitute medical advice; discuss your records and testing with your healthcare professionals.